ChartRow logo
PeersEWZBHSNNGEHCPHGDXCM
Share this page

STE financial statements

The full income statement, balance sheet, and cash-flow statement for STERIS plc (Ireland) (STE), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.

Financial overview#

Revenue

5Y CAGR +13.8%5Y CAGR +13.8%YoY +7.3%
$6B TTM$1.5B Q1 '27
FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26TTM
Q1 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26Q1 '27

Gross profit

5Y CAGR +14.4%5Y CAGR +14.4%YoY +8.9%
$2.7B TTM$684.2M Q1 '27
FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26TTM
Q1 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26Q1 '27

Operating income

5Y CAGR +15.0%5Y CAGR +15.0%YoY +16.2%
$1.1B TTM$285.8M Q1 '27
FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26TTM
Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26Q1 '27

Net income

5Y CAGR +14.5%5Y CAGR +14.5%YoY +12.8%
$805.1M TTM$200.1M Q1 '27
FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26TTM
Q1 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26Q1 '27

EPS (diluted)

5Y CAGR +11.4%5Y CAGR +11.4%YoY +14.0%
$8.18 TTM$2.04 Q1 '27
FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26TTM
Q1 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26Q1 '27

Operating cash flow

5Y CAGR +14.2%5Y CAGR +14.2%YoY −12.6%
$1.3B TTM$367.1M Q1 '27
FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26TTM
Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26Q1 '27

Capital expenditure

5Y CAGR +9.1%5Y CAGR +9.1%YoY −6.5%
$362.9M TTM$87.5M Q1 '27
FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26TTM
Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26Q1 '27

Free cash flow

5Y CAGR +16.6%5Y CAGR +16.6%YoY −14.3%
$925.6M TTM$279.6M Q1 '27
FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26TTM
Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26Q1 '27

Shares (diluted)

5Y +14.9%5Y +14.9%YoY −0.9%
98.4M TTM97.9M Q1 '27
FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26TTM
Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26Q1 '27

Dividend per share

5Y CAGR +9.4%5Y CAGR +9.4%YoY +10.5%
$2.52 TTM$0.63 Q1 '27
FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26TTM
Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26Q1 '27

Shares outstanding (point-in-time)

2024-06 98.6M2024-09 98.7M2024-12 98.3M2025-03 98.4M2025-06 98.5M2025-09 98.1M2025-12 98.1M2026-03 97.6M2026-06 97.5M-1.1% over 8 periods

SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.

PeriodRangeOrderChangeFiguresAs-reported fiscal years.
Line itemTrendFY2026FY2025FY2024FY2023FY2022
Income Statementas ofMar 31 ’26as ofMar 31 ’25as ofMar 31 ’24as ofMar 31 ’23as ofMar 31 ’22
Revenue5.94B+8.7%5.46B+6.2%5.14B+13.3%4.54B+7.4%4.22B+35.9%
2.63B+9.3%2.40B+8.3%2.22B+12.0%1.98B+5.2%1.88B+40.2%
Cost of revenue3.31B+8.3%3.06B+4.7%2.92B+14.3%2.56B+9.2%2.34B+32.6%
1.52B-0.7%1.54B+11.2%1.38B+16.2%1.19B-15.3%1.41B+76.8%
Research & development113M+4.9%108M+3.8%104M+5.3%98.5M+13.6%86.7M+30.7%
Selling, general & administrative1.41B+5.5%1.33B+6.5%1.25B+14.8%1.09B-17.3%1.32B+80.3%
Restructuring3.40M-94.5%62.3M+40.3%44.4M+9054.6%485K+910.4%48.0K+101.6%
Amortization of intangibles268M-2.9%276M+2.9%268M+3.3%260M-1.9%265M+205.9%
Operating income1.10B+27.1%867M+3.6%836M+5.7%791M+65.6%478M-12.9%
Interest expense60.7M-29.7%86.3M-40.2%144M+33.8%108M+20.6%89.5M+140.7%
Other non-operating income9.80M+16.7%8.40M-23.6%11.0M+482.1%-2.88M-145.8%6.28M-1.0%
Gain (loss) on equity securities200K-77.8%900K-15.1%1.06M+190.1%-1.18M-51.7%-775K-230.5%
Pre-tax income1.05B+31.5%796M+13.3%703M+3.3%680M+85.5%367M-29.1%
Income tax262M+42.0%185M+23.5%150M+20.5%124M+50.7%82.3M-31.8%
782M+27.3%615M+62.5%378M+253.4%107M-56.1%244M-38.6%
Net income to non-controlling interest2.80M+100.0%1.40M-22.2%1.80M+247.9%-1.22M-19.5%-1.02M-92.1%
Net income to common782M+27.3%615M+62.5%378M+253.4%107M-56.1%244M-38.6%
$7.93+27.9%$6.20+62.7%$3.81+256.1%$1.07-56.9%$2.48-46.4%
EPS (basic)$7.97+27.7%$6.24+62.9%$3.83+257.9%$1.07-57.2%$2.50-46.4%
Weighted-avg shares (basic)98.2M-0.4%98.6M-0.2%98.8M-0.9%99.7M+2.2%97.5M+14.5%
Weighted-avg shares (diluted)98.7M-0.4%99.1M-0.3%99.4M-0.8%100M+2.0%98.3M+14.5%
Dividends per share$2.46+10.3%$2.23+9.9%$2.03+10.3%$1.84+8.9%$1.69+7.6%
Balance Sheetas ofMar 31 ’26as ofMar 31 ’25as ofMar 31 ’24as ofMar 31 ’23as ofMar 31 ’22
2.39B+19.7%2.00B-30.3%2.87B+42.6%2.01B+7.0%1.88B+55.1%
Cash & equivalents440M+156.0%172M-17.1%207M-0.6%208M-40.2%348M+57.9%
Accounts receivable1.09B+4.7%1.04B+3.5%1.01B+16.6%865M+8.3%799M+31.1%
Inventory632M+8.7%581M-13.8%675M+11.6%604M+5.1%575M+82.5%
10.7B+5.8%10.1B-8.3%11.1B+2.2%10.8B-5.3%11.4B+73.8%
Property, plant & equipment2.16B+10.5%1.96B+10.8%1.77B+8.1%1.63B+5.2%1.55B+25.7%
Operating lease right-of-use155M-0.8%156M-9.7%173M+4.0%167M-11.6%188M+25.5%
Goodwill4.19B+2.4%4.10B+0.6%4.07B+4.9%3.88B-11.9%4.40B+45.5%
Intangible assets1.62B-12.6%1.85B-12.5%2.12B+2.1%2.08B-37.6%3.33B+270.5%
Other non-current assets211M+154.7%83.0M+25.4%66.2M-15.0%77.9M+10.2%70.7M+34.0%
1.15B+12.0%1.02B+9.8%931M+8.0%862M-6.5%922M+59.6%
Accounts payable339M+20.7%281M+11.6%252M-4.7%264M+17.0%226M+43.8%
Accrued liabilities402M+9.2%368M+15.1%320M+7.3%298M-2.8%307M+39.0%
Short-term & current debt119M-4.9%125M+45.5%85.9M+43.2%60.0M-58.0%143M
Current lease liability35.8M+4.7%34.2M+9.5%31.2M+3.9%30.1M-17.6%36.5M+60.1%
3.54B+0.3%3.53B-25.6%4.75B+0.3%4.73B-3.0%4.88B+81.8%
Long-term debt1.81B-5.5%1.92B-38.5%3.12B+3.4%3.02B+2.5%2.95B+78.5%
Non-current lease liability120M-4.0%125M-14.6%146M+4.5%140M-10.0%155M+19.6%
Other non-current liabilities71.7M+15.8%61.9M-13.5%71.5M-6.0%76.1M+0.7%75.6M-14.1%
7.18B+8.8%6.60B+4.8%6.30B+3.7%6.08B-7.0%6.53B+68.3%
Common stock4.28B-3.2%4.42B-2.7%4.54B+1.3%4.49B-5.4%4.74B+136.8%
Retained earnings3.02B+21.8%2.48B+18.6%2.09B+9.2%1.91B-4.4%2.00B+3.1%
Accumulated other comprehensive income-113M+61.3%-292M+11.1%-329M-2.5%-321M-52.9%-210M-242.6%
Non-controlling interest13.6M+9.7%12.4M-5.9%13.2M+32.2%9.97M-18.8%12.3M+17.2%
Total equity incl. non-controlling7.20B+8.8%6.62B+4.8%6.32B+3.7%6.09B-7.0%6.54B+68.2%
Total liabilities & equity10.7B+5.8%10.1B-8.3%11.1B+2.2%10.8B-5.3%11.4B+73.8%
Common shares issued97.8M-0.5%98.3M-0.6%98.9M+0.3%98.6M-1.4%100M+17.2%
Common shares outstanding97.8M-0.5%98.3M-0.6%98.9M+0.3%98.6M-1.4%100M+17.2%
Shares outstanding (cover)97.6M-0.8%98.4M-0.5%98.9M+0.3%98.7M-1.4%100M+17.2%
Cash Flowas ofMar 31 ’26as ofMar 31 ’25as ofMar 31 ’24as ofMar 31 ’23as ofMar 31 ’22
1.34B+16.8%1.15B+18.0%973M+28.6%757M+10.5%685M-0.7%
Depreciation & amortization487M+2.2%476M-15.7%565M+2.2%553M-0.0%553M+152.3%
Intangible amortization268M-2.9%276M+2.9%268M+3.3%260M-1.9%265M+205.9%
Share-based compensation61.7M+7.5%57.4M+1.6%56.5M+45.1%39.0M-32.4%57.7M+122.1%
Deferred income taxes-16.9M+77.9%-76.5M+41.8%-131M+29.3%-186M-74.4%-107M-2614.6%
Change in receivables25.1M-12.8%28.8M-77.5%128M-3.9%133M+156.5%52.0M+530.3%
Change in inventory24.0M+132.8%-73.1M-294.9%37.5M-69.7%124M+20.4%103M+2830.8%
Change in payables51.1M+52.1%33.6M+276.8%-19.0M-135.6%53.3M+258.3%14.9M+306.4%
-513M-231.8%389M+143.8%-887M-131.5%-383M+42.5%-667M+42.2%
Capital expenditure369M-0.3%370M+2.7%360M-0.5%362M+25.9%288M+20.2%
Free cash flow972M+25.0%778M+26.9%613M+55.2%395M-0.6%397M-11.8%
Acquisitions20.1M-62.8%54.1M-90.1%546M+1183.2%42.6M-92.3%550M-39.5%
Purchases of investments134M+1140.7%10.8M+620.0%1.50M0.000.00-100.0%
Proceeds from sale of PP&E10.5M+14.1%9.20M+24.3%7.40M-49.3%14.6M+737.9%1.74M+206.0%
Other investing activities———0.000.00-100.0%
-568M+63.9%-1.57B-1745.5%-85.2M+82.9%-499M-530.6%116M-66.5%
Long-term debt issued0.000.000.000.00-100.0%1.35B
Long-term debt repaid0.000.000.000.000.00-100.0%
Common stock issued0.000.000.000.000.00
Common stock repurchased236M+11.5%211M+1690.7%11.8M-96.2%309M+453.2%55.8M+280.8%
Dividends paid242M+10.0%220M+9.6%201M+9.3%183M+12.5%163M+21.9%
Other financing activities32.9M+29.0%25.5M+142.9%10.5M+474.4%1.83M-81.8%10.1M-62.3%
FX effect on cash7.20M+3500.0%200K+109.5%-2.10M+85.9%-14.9M-136.2%-6.29M-131.7%
Net change in cash268M+858.9%-35.3M-2615.4%-1.30M+99.1%-140M-209.5%128M+229.0%
Interest paid64.7M-27.6%89.4M-37.1%142M+31.1%108M+28.1%84.7M+133.6%
Income taxes paid289M+5.6%274M+0.8%271M+6.5%255M+84.0%138M+26.2%
Valuation Ratiosas ofMar 31 ’26as ofMar 31 ’25as ofMar 31 ’24as ofMar 31 ’23as ofMar 31 ’22
Market cap21.6B-2.9%22.3B+0.3%22.2B+17.8%18.9B-22.0%24.2B+48.8%
P/E27.6×-23.7%36.3×-7.5%39.2×-77.8%176.3×+77.7%99.2×+142.5%
P/S3.6×-10.7%4.1×-8.1%4.4×+6.8%4.2×-27.4%5.7×+9.5%
P/B3.0×-10.8%3.4×-2.6%3.5×+11.5%3.1×-16.2%3.7×-11.6%
P/FCF22.2×-22.3%28.6×-23.4%37.4×-21.7%47.8×-21.6%60.9×+68.7%
Earnings yield3.6%+31.1%2.8%+8.1%2.6%+349.8%0.57%-43.7%1.0%-58.8%
FCF yield4.5%+28.8%3.5%+30.6%2.7%+27.7%2.1%+27.5%1.6%-40.7%
Dividend yield1.1%+13.1%0.98%+9.0%0.90%-6.1%0.96%+37.6%0.70%-15.2%
Source filing10-K10-K10-K10-K10-K

About this data

Source: STE’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all STE filings on SEC EDGAR → Not investment advice.